Schizophrenia

  • Most Topular Stories

  • FDA Sheds Light on Deaths Associated With Injectable Schizophrenia Drug Olanzapine

    Schizophrenia News
    24 Mar 2015 | 10:35 am
    The FDA has concluded a review of a study undertaken to determine the cause of elevated levels of the injectable schizophrenia drug olanzapine pamoate in two patients who died. The study results were inconclusive.
  • Dopamine

    About.com Schizophrenia: Most Popular Articles
    30 Mar 2015 | 6:21 am
    Definition of the term, dopamine
  • Schizophrenia versus schizoaffective disorder

    About.com Schizophrenia: What's Hot Now
    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    Schizophrenia and schizoaffective are two different disorders. This article discusses the relevant differences why that matters. From your About Schizophrenia Expert Guide.
  • Drug Deaths From Schizophrenia Medication Deemed 'Inconclusive,' Says FDA

    schizophrenic.com
    M Tyler
    24 Mar 2015 | 10:44 am
    An FDA review of olanzapine, a drug used to treat schizophrenia, was found to be inconclusive in regards to two patient deaths, according to a statement released by the government agency. In June 2013, the FDA reported the deaths, where two individuals were given intramuscular injections - in appropriate doses - of olanzapine (Zyprexa Relprevv) and died within a few days. Accordingly, the drug's manufacturer Eli Lilly and Company were asked to conduct animal trials to test whether or not the drug entered the patients' bloodstreams in a rapid but delayed manner - which can cause overdose, coma…
  • Minerva's (NERV) CEO Remy Luthringer on Q4 2014 Results - Earnings Call Transcript

    Schizophrenia News
    26 Mar 2015 | 7:33 pm
    Welcome to Minerva Neurosciences Fourth Quarter and Year-End 2014 Conference Call. At this time, all participants are in a listen-only mode.
  • add this feed to my.Alltop

    schizophrenia - Google News

  • New Test and App to Diagnose Schizophrenia - WTAJ

    30 Mar 2015 | 11:25 am
    WTAJNew Test and App to Diagnose SchizophreniaWTAJRoughly three-million Americans suffer from schizophrenia, a mental disorder that can cause people to hear voices or have hallucinations. Currently, doctors diagnose the disorder in a very subjective way. But that could soon change. Isaac has Healthy Living: Spotting Schizophrenia9&10 Newsall 2 news articles »
  • Infant Brain Abnormalities Show Schizophrenia Genesis - Medscape

    30 Mar 2015 | 9:46 am
    MedscapeInfant Brain Abnormalities Show Schizophrenia GenesisMedscapeCOLORADO SPRINGS, Colorado — Neonates of mothers with schizophrenia or bipolar illness show abnormalities in the amygdala in the earliest stages of brain development that are consistent with alterations associated with schizophrenia, according to ...
  • Three-Month Paliperidone Palmitate to Delay Relapse in Schizophrenia: Phase ... - Monthly Prescribing Reference

    30 Mar 2015 | 8:00 am
    Three-Month Paliperidone Palmitate to Delay Relapse in Schizophrenia: Phase Monthly Prescribing ReferenceFinal analysis results were consistent with that of the interim analysis, confirming three-month paliperidone palmitate's superiority over placebo for delaying time to relapse of schizophrenia symptoms (HR 3.81; 95% CI: 2.08–6.99; p<0.0001; median time New Study Published in JAMA Psychiatry Found Three-Month Paliperidone PR Newswire (press release)all 2 news articles »
  • Should Schizophrenia Be Renamed to Avoid Stigma? - Psychiatry Advisor

    30 Mar 2015 | 5:58 am
    Should Schizophrenia Be Renamed to Avoid Stigma?Psychiatry AdvisorA group of researchers are arguing that the term “schizophrenia” should be scrapped and replaced with a new term that will help to eliminate the stigma associated with the disorder. Antonio Lasalvia, MD, PhD, a psychiatrist with the University of
  • Researchers Want To Rename Schizophrenia, Help Lessen Mental Health Stigma - Medical Daily

    27 Mar 2015 | 8:25 am
    Medical DailyResearchers Want To Rename Schizophrenia, Help Lessen Mental Health StigmaMedical DailyThe National Alliance on Mental Illness (NAMI) defines schizophrenia as “a serious mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions and relate to others.” But lately, more people are speaking out and more »
 
  • add this feed to my.Alltop

    Schizophrenia News

  • New Study Published in JAMA Psychiatry Found Three-Month Paliperidone ...

    29 Mar 2015 | 12:11 am
    Results of the study served as the basis for the recent New Drug Application filing for three-month paliperidone palmitate injection to treat schizophrenia in adults with the U.S. Food and Drug Administration by Janssen Research & Development, LLC, , the study sponsor. The FDA granted the filing Priority Review status in January, with a regulatory action date of If approved, the treatment would enable patients to receive injections once every three months, compared to currently available formulations that are administered monthly, or oral medicines that must be taken daily.
  • Researchers Want To Rename Schizophrenia, Help Lessen Mental Health Stigma

    27 Mar 2015 | 10:56 am
    The National Alliance on Mental Illness defines schizophrenia as "a serious mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions and relate to others." But lately, more people are speaking out against the term schizophrenia - translated from the Greek phrase skhizein phren , or "to split mind" - which saying the word itself is stigmatized and harmful to use.
  • Minerva's (NERV) CEO Remy Luthringer on Q4 2014 Results - Earnings Call Transcript

    26 Mar 2015 | 7:33 pm
    Welcome to Minerva Neurosciences Fourth Quarter and Year-End 2014 Conference Call. At this time, all participants are in a listen-only mode.
  • Newron Shareholders Authorize Allocation ...

    24 Mar 2015 | 2:39 pm
    Newron Pharmaceuticals S.p.A. , a research and development company focused on novel Central Nervous System and pain therapies, announced that shareholders today authorized the Company to allocate up to 1.3 million shares to raise capital. "Newron is committed to bringing much needed new therapies to patients with CNS diseases," said Stefan Weber, CEO of Newron.
  • FDA Sheds Light on Deaths Associated With Injectable Schizophrenia Drug Olanzapine

    24 Mar 2015 | 10:35 am
    The FDA has concluded a review of a study undertaken to determine the cause of elevated levels of the injectable schizophrenia drug olanzapine pamoate in two patients who died. The study results were inconclusive.
  • add this feed to my.Alltop

    MedWorm: Schizophrenia

  • Prefrontal dysfunction and a monkey model of schizophrenia

    30 Mar 2015 | 7:50 am
    Abstract The prefrontal cortex is implicated in cognitive functioning and schizophrenia. Prefrontal dysfunction is closely associated with the symptoms of schizophrenia. In addition to the features typical of schizophrenia, patients also present with aspects of cognitive disorders. Based on these relationships, a monkey model mimicking the cognitive symptoms of schizophrenia has been made using treatment with the non-specific competitive N-methyl-D-aspartate receptor antagonist, phencyclidine. The symptoms are ameliorated by atypical antipsychotic drugs such as clozapine. The beneficial…
  • How and Why Affective and Reactive Virtual Agents Will Bring New Insights on Social Cognitive Disorders in Schizophrenia? An Illustration with a Virtual Card Game Paradigm

    30 Mar 2015 | 6:59 am
    Ali Oker, Elise Prigent, Matthieu Courgeon, Victoria Eyharabide, Mathieu Urbach, Nadine Bazin, Michel-Ange Amorim, Christine Passerieux, Jean-Claude Martin and Eric Brunet-Gouet (Source: Frontiers in Human Neuroscience)
  • Specificity of facial emotion recognition impairments in patients with multi-episode schizophrenia

    29 Mar 2015 | 4:00 pm
    Conclusion Compared to controls patients with schizophrenia displayed more difficulties in processing of social information compared to non-social information. These results support the hypothesis that facial emotion recognition impairment is a relatively distinct entity within the domain of cognitive dysfunction in schizophrenia. (Source: Schizophrenia Research: Cognition)
  • P50 sensory gating deficits in schizotypy

    29 Mar 2015 | 4:00 pm
    Publication date: August 2015 Source:Personality and Individual Differences, Volume 82 Author(s): Haeme R.P. Park , Vanessa K. Lim , Ian J. Kirk , Karen E. Waldie Sensory gating is the ability to filter out irrelevant stimuli from the environment. Individuals with schizophrenia consistently demonstrate deficits in this ability leading to sensory overload and cognitive fragmentation. This dysfunction has also been found in schizotypy, which is defined as a manifestation of nonclinical symptoms qualitatively similar to those found in schizophrenia. In the present study, auditory sensory gating…
  • Acute exacerbation of psychiatric symptoms during influenza treatment with oseltamivir in chronic schizophrenia

    29 Mar 2015 | 4:00 pm
    Publication date: Available online 29 March 2015 Source:Journal of the Chinese Medical Association Author(s): Chen-Chia Lan , Chia-Chien Liu , Ying-Sheue Chen Influenza treatment and prophylaxis with oseltamivir are critically important in reducing the morbidity and mortality of patients in chronic psychiatric facilities. Abnormal behavior, delusions, perceptual disturbances, mania, and depression have all been reported as oseltamivir-related psychiatric side effects. We hereby report two chronic schizophrenia patients in Taiwan manifesting psychiatric instability who were being treated with…
 
  • add this feed to my.Alltop

    About.com Schizophrenia: What's Hot Now

  • Schizophrenia versus schizoaffective disorder

    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    Schizophrenia and schizoaffective are two different disorders. This article discusses the relevant differences why that matters. From your About Schizophrenia Expert Guide.
  • Schizophrenia: Early Diagnosis and treatment

    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    How early can schizophrenia be diagnosed? Are there warning signs that can guide prevention, early diagnosis and treatment?
  • What Causes Schizophrenia?

    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    Stress alone cannot cause schizophrenia, although schizophrenia creates a lot of stress in families' and individuals' lives. However, people with schizophrenia are sensitive to stress and must manage a routine in order to avoid relapse.
  • What Do Hallucinations Feel Like in Schizophren...

    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    Hallucinations are part of schizophrenia. This article focuses on what experiencing hallucinations feels like from a patient's perspective.
  • Who Gets Schizophrenia?

    schizophrenia.guide@about.com
    30 Mar 2015 | 4:20 am
    Although the overall incidence of schizophrenia in the United States is close to 1%, different groups have a greater or lesser likelihood of developing the illness. This article from your About Guide to Schizophrenia reviews the incidence of schizophrenia among different groups of people, which scientists are using as clues to help find the cause.
 
  • add this feed to my.Alltop

    About.com Schizophrenia: Most Popular Articles

  • Liking the effects of d-amphetamines linked to...

    30 Mar 2015 | 6:21 am
    Genetic predisposition to liking amphetamine linked to decreased risk for schizophrenia and ADHD
  • What It's Like to Have Schizophrenia

    30 Mar 2015 | 6:21 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more.
  • Dopamine

    30 Mar 2015 | 6:21 am
    Definition of the term, dopamine
  • How Schizophrenia Is Diagnosed

    30 Mar 2015 | 6:21 am
    The better you understand the language and the process of diagnosing schizophrenia, the better you can communicate with your doctor. Remember that only a psychologist or psychiatrist can rule out or diagnose schizophrenia.
  • How do you cope with schizophrenia?

    30 Mar 2015 | 6:21 am
    Be prepared! Help your doctor help you! The best results are seen when doctors and patients work together.
  • add this feed to my.Alltop

    Schizophrenia Bulletin - Advance Access

  • Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study

    McCollum, L. A., Walker, C. K., Roche, J. K., Roberts, R. C.
    27 Mar 2015 | 11:16 pm
    The cause of schizophrenia (SZ) is unknown and no single region of the brain can be pinpointed as an area of primary pathology. Rather, SZ results from dysfunction of multiple neurotransmitter systems and miswiring between brain regions. It is necessary to elucidate how communication between regions is disrupted to advance our understanding of SZ pathology. The nucleus accumbens (NAcc) is a prime region of interest, where inputs from numerous brain areas altered in SZ are integrated. Aberrant signaling in the NAcc is hypothesized to cause symptoms of SZ, but it is unknown if these…
  • The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial

    Kimhy, D., Vakhrusheva, J., Bartels, M. N., Armstrong, H. F., Ballon, J. S., Khan, S., Chang, R. W., Hansen, M. C., Ayanruoh, L., Lister, A., Castren, E., Smith, E. E., Sloan, R. P.
    23 Mar 2015 | 9:05 pm
    Individuals with schizophrenia display substantial neurocognitive deficits for which available treatments offer only limited benefits. Yet, findings from studies of animals, clinical and nonclinical populations have linked neurocognitive improvements to increases in aerobic fitness (AF) via aerobic exercise training (AE). Such improvements have been attributed to up-regulation of brain-derived neurotrophic factor (BDNF). However, the impact of AE on neurocognition, and the putative role of BDNF, have not been investigated in schizophrenia. Employing a proof-of-concept, single-blind,…
  • Brain Correlates of Cognitive Remediation in Schizophrenia: Activation Likelihood Analysis Shows Preliminary Evidence of Neural Target Engagement

    Ramsay, I. S., MacDonald, A. W.
    23 Mar 2015 | 1:23 am
    Cognitive remediation training (CRT) for schizophrenia has been found to improve cognitive functioning and influence neural plasticity. However, with various training approaches and mixed findings, the mechanisms driving generalization of cognitive skills from CRT are unclear. In this meta-analysis of extant imaging studies examining CRT’s effects, we sought to clarify whether varying approaches to CRT suggest common neural changes and whether such mechanisms are restorative or compensatory. We conducted a literature search to identify studies appropriate for inclusion in an activation…
  • The Magic of Movement; the Potential of Exercise to Improve Cognition

    Sommer, I. E., Kahn, R. S.
    23 Mar 2015 | 1:23 am
  • Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research

    Dazzan, P., Arango, C., Fleischacker, W., Galderisi, S., Glenthoj, B., Leucht, S., Meyer-Lindenberg, A., Kahn, R., Rujescu, D., Sommer, I., Winter, I., McGuire, P.
    23 Mar 2015 | 1:23 am
    Magnetic Resonance Imaging (MRI) measures are promising outcome markers for schizophrenia, since regional frontal and temporal grey matter volumes reductions, and enlargement of the ventricles, have been associated with outcome in this disorder. However, a number of methodological issues have limited the potential clinical utility of these findings. This article reviewed studies that examined brain structure at illness onset as a predictor of outcome, discusses the limitations of the findings, and highlights the challenges that would need to be addressed if structural data are to inform the…
  • add this feed to my.Alltop

    Schizophrenia Research

  • Editorial Board

    31 Mar 2015 | 5:00 pm
  • Creativity and positive symptoms in schizophrenia revisited: Structural connectivity analysis with diffusion tensor imaging

    Shuraku Son, Manabu Kubota, Jun Miyata, Hidenao Fukuyama, Toshihiko Aso, Shin-ichi Urayama, Toshiya Murai, Hidehiko Takahashi
    29 Mar 2015 | 5:00 pm
    Both creativity and schizotypy are suggested to be manifestations of the hyperactivation of unusual or remote concepts/words. However, the results of studies on creativity in schizophrenia are diverse, possibly due to the multifaceted aspects of creativity and difficulties of differentiating adaptive creativity from pathological schizotypy/positive symptoms. To date, there have been no detailed studies comprehensively investigating creativity, positive symptoms including delusions, and their neural bases in schizophrenia.
  • Spanish version of the social network questionnaire in schizophrenia patients’ caregivers

    José Miguel Ribé, Manel Salamero, Carles Pérez-Testor, Àngels Valero, Maria Carmen García
    29 Mar 2015 | 5:00 pm
    Dear Editor,
  • Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia

    Enrique Basurto, Oscar González Flores, Kurt Leroy Hoffman
    29 Mar 2015 | 5:00 pm
    Deficits in glutamate N-methyl-d-aspartic acid (NMDA) receptor signaling are believed to contribute to the pathophysiology of schizophrenia, motivating the search for new pharmacotherapies based on augmenting the activity of this receptor (Balu and Coyle, 2015). In the rodent, hyperlocomotion and deficits in object recognition memory acutely induced by NMDA receptor antagonists, such as MK-801, are useful pharmacological models for positive and cognitive symptoms of schizophrenia, respectively (Porsolt et al., 2010).
  • Insight in paranoia: The role of experiential avoidance and internalized stigma

    Carmen Valiente, Maria Provencio, Regina Espinosa, Almudena Duque, Franziska Everts
    29 Mar 2015 | 5:00 pm
    Evidence suggests that insight in psychosis has been related to treatment adherence, recovery and good prognosis, but also to depression, low self-esteem, and diminished quality of life. Thus, insight might not be advantageous under all circumstances. Internalized-stigma (i.e. self-acceptance of stigmatizing images of illness) and experiential avoidance (i.e. unwillingness to experience negative private events) have been proposed as moderating variables between insight, and psychological health variables and/or distress.
 
  • add this feed to my.Alltop

    Schizophrenia Research

  • Insight in paranoia: The role of experiential avoidance and internalized stigma

    Carmen Valiente, Maria Provencio, Regina Espinosa, Almudena Duque, Franziska Everts
    29 Mar 2015 | 5:00 pm
    Evidence suggests that insight in psychosis has been related to treatment adherence, recovery and good prognosis, but also to depression, low self-esteem, and diminished quality of life. Thus, insight might not be advantageous under all circumstances. Internalized-stigma (i.e. self-acceptance of stigmatizing images of illness) and experiential avoidance (i.e. unwillingness to experience negative private events) have been proposed as moderating variables between insight, and psychological health variables and/or distress.
  • Creativity and positive symptoms in schizophrenia revisited: Structural connectivity analysis with diffusion tensor imaging

    Shuraku Son, Manabu Kubota, Jun Miyata, Hidenao Fukuyama, Toshihiko Aso, Shin-ichi Urayama, Toshiya Murai, Hidehiko Takahashi
    29 Mar 2015 | 5:00 pm
    Both creativity and schizotypy are suggested to be manifestations of the hyperactivation of unusual or remote concepts/words. However, the results of studies on creativity in schizophrenia are diverse, possibly due to the multifaceted aspects of creativity and difficulties of differentiating adaptive creativity from pathological schizotypy/positive symptoms. To date, there have been no detailed studies comprehensively investigating creativity, positive symptoms including delusions, and their neural bases in schizophrenia.
  • Spanish version of the social network questionnaire in schizophrenia patients’ caregivers

    José Miguel Ribé, Manel Salamero, Carles Pérez-Testor, Àngels Valero, Maria Carmen García
    29 Mar 2015 | 5:00 pm
    Dear Editor,
  • Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia

    Enrique Basurto, Oscar González Flores, Kurt Leroy Hoffman
    29 Mar 2015 | 5:00 pm
    Deficits in glutamate N-methyl-d-aspartic acid (NMDA) receptor signaling are believed to contribute to the pathophysiology of schizophrenia, motivating the search for new pharmacotherapies based on augmenting the activity of this receptor (Balu and Coyle, 2015). In the rodent, hyperlocomotion and deficits in object recognition memory acutely induced by NMDA receptor antagonists, such as MK-801, are useful pharmacological models for positive and cognitive symptoms of schizophrenia, respectively (Porsolt et al., 2010).
  • Age at onset mixture analysis and systematic comparison in schizophrenia spectrum disorders: Is the onset heterogeneity dependent on heterogeneous diagnosis?

    Behdin Nowrouzi, Roy Kamhi, Jayi Hu, James L. Kennedy, Michelle Matmari, Vincenzo De Luca
    25 Mar 2015 | 5:00 pm
    A major obstacle to the identification of the neurobiological correlates of schizophrenia is the substantial diagnostic heterogeneity of this disorder. Dividing schizophrenia into “early” and “late” subtypes may reduce heterogeneity and facilitate identification of biomarkers related to this disease. Our objective was to assess the presence of different sub-groups in schizophrenia by age at onset analysis. The participants in this study were 612 unrelated patients with schizophrenia. Admixture analysis was applied in order to identify a model of separate normal distributions of age at…
  • add this feed to my.Alltop

    Schizophrenia News -- ScienceDaily

  • Brain networks differ among those with severe schizophrenia, study shows

    18 Mar 2015 | 10:03 am
    People with a severe form of schizophrenia have major differences in their brain networks compared to others with schizophrenia, bipolar disorder and healthy individuals, a new study shows. Schizophrenia, which affects one in 100 people, is generally known for symptoms of delusions and hallucinations, which can be treated with antipsychotic medications. However, lack of motivation and social withdrawal are also characteristic symptoms of the illness.
  • Finger lengths may indicate risk of schizophrenia in males

    16 Mar 2015 | 10:49 am
    Research suggests that the ratio of the lengths of the index finger and the ring finger in males may be predictive of a variety of disorders related to disturbed hormonal balance. When the index finger is shorter than the ring finger, this results in a small 2D:4D ratio, pointing to a high exposure to testosterone in the uterus.
  • Blood pressure drug protects against symptoms of multiple sclerosis in animal models

    13 Mar 2015 | 5:32 am
    An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears to enhance an innate cellular mechanism that protects myelin-producing cells.
  • Rat brains point to lead's role in schizophrenia

    11 Mar 2015 | 1:05 pm
    A study of the brains of rats exposed to lead has uncovered striking similarities with what is known about the brains of human schizophrenia patients, adding compelling evidence that lead is a factor in the onset of schizophrenia.
  • Received wisdom about mental illness challenged by new report

    11 Mar 2015 | 9:44 am
    A new report challenges received wisdom about the nature of mental illness and has led to widespread media coverage and debate in the UK. Many people believe that schizophrenia is a frightening brain disease that makes people unpredictable and potentially violent, and can only be controlled by medication. However the UK has been at the forefront of research into the psychology of psychosis conducted over the last twenty years, and which reveals that this view is false.
  • add this feed to my.Alltop

    Collagen @Aloha.bg

  • Колаген комплекс МЕГА

    7 Mar 2015 | 4:08 am
    Колаген комплекс Мега съдържа Натурален колаген за лице от Inventia + Колаген таблетки за пиене Invita Skin Beauty + Витамин C Плюс достатъчни за 2 месеца. Натурален колаген за лице от Inventia 50ml Действие на Натурален колаген за лице от Inventia Увеличава опъването на кожата, което прави мимическите бръчките по-малко забележими Гелът стимулира…
  • Прополис Bee Pure капсули

    28 Jan 2015 | 6:38 am
    ПРОПОЛИСЪТ ПРЕДПАЗВА И ПОДПОМАГА ЕСТЕСТВЕНИТЕ ЗАЩИТНИ МЕХАНИЗМИ НА ОРГАНИЗМА Прополис Bee Pure капсули се препоръчва при грип, отслабен имунитет и простуда. Висококачествен натурален прополис, който можете да намерите само в кошера, със 100% активни съставки – без алкохол, без глутен, без захар. Ръчно производство без химикали…
  • Прополис Bee Pure GASTRO

    28 Jan 2015 | 6:33 am
    Прополис Bee Pure GASTRO – ПОМАГА ПРИ СТОМАШНИ И ЧРЕВНИ ПРОБЛЕМИ Джинджифил – успокоителен ефект за стомаха и червата. Bee Pure прополис с повече от 300 биологично активни съединения. Bee Pure цветен прашец от специалната далматинска билка Цистрозе: богата на витамини (A, B1, B2, B6, C и E), минерали и микроелементи (калций, магнезий, мед и…
  • Цветен прашец Bee Pure

    28 Jan 2015 | 3:02 am
    ЦВЕТНИЯТ ПРАШЕЦ Е ИЗВОР НА ЧИСТИ, НАТУРАЛНИ ВИТАМИНИ И МИНЕРАЛИ Предназначен за тези, които спортуват и са физически активни. Препоръчва се при умора и стрес в ежедневието. Пчелният цветен прашец се събира от специалната далматинска билка Цистрозе: богата на витамини (A, B1, B2, B6, C и E), минерали и микроелементи (калций, магнезий,…
  • Пчелно млечице GELEE ROYALE

    28 Jan 2015 | 2:53 am
    Пчелното млечице Bee Pure във формата на таблетки за смучене съдържа чисто пчелно млечице, което се изсушава чрез постепенно замразяване и по този начин изцяло запазва естествените си съставки. Тъй като пчелното млечице е предназначено за пчелите, затова преработено в течна форма, е добре усвоимо само в чувствителни им стомаси.
 
  • add this feed to my.Alltop

    Schizophrenia Society of Nova Scotia

  • Families Matter in Mental Health: An Education and Support Program -- Berwick, Nova Scotia

    30 Mar 2015 | 4:00 am
    Begins tomorrow, March 31st, 4:00 pmBerwick, Nova ScotiaPlease click on the image to magnify it.To download a PDF version of the above poster, please click here.Please click here for a map of the location of 185 Commercial Street in Berwick.For further information on Families Matter in Mental Health, please click here.
  • Families Matter in Mental Health: An Education and Support Program -- Stellarton, Nova Scotia

    30 Mar 2015 | 3:30 am
    Begins this Wednesday, April 1st, 6:30 pmStellarton, Nova ScotiaPlease click on the image to magnify it.To download a PDF version of the above poster, please click here.Please click here for a map of the location of 266 Foord Street in Stellarton.For further information on Families Matter in Mental Health, please click here.
  • The "From Recovery to Discovery" Mental Health Peer Support Group - Halifax

    30 Mar 2015 | 3:00 am
    This Thursday, April 2nd, 6:30 pmMeetingsEvery Thursday Evening6:30 pm to 8:30 pmCommunity RoomAtlantic Superstore – Barrington Street 1075 Barrington StreetHalifax, Nova Scotia Plenty of free parking!The Atlantic Superstore – Barrington Street is on the 3, 7, 9, and 41 Metro Transit bus routes.The From Recovery to Discovery Mental Health Peer Support Group is open to anyone affected by any type of mental illness, and this includes family members and friends.Free! Thursday, April 2nd, 2015, 6:30 pmCaldy GrangeSupported Housing in the Community for People Recovering from Mental…
  • Families Matter in Mental Health: An Education and Support Program -- Inverness, Nova Scotia

    30 Mar 2015 | 2:30 am
    Begins Wednesday, April 8th, 5:30 pmInverness, Nova ScotiaPlease click on the image to magnify it.To download a PDF version of the above poster, please click here.Please click here for a map of the location of Inverness Consolidated Memorial Hospital.For further information on Families Matter in Mental Health, please click here.
  • Families Matter in Mental Health: An Education and Support Program -- Halifax Regional Municipality

    30 Mar 2015 | 2:00 am
    Begins Wednesday, April 8th, 6:00 pmCole HarbourPlease click on the image to magnify it.To download a PDF version of the above flyer, please click here.To download the Families Matter in Mental Health provincial brochure (PDF), please click here.Also see:Supporting Families in Recovery - Capital Health Addictions and Mental Health ProgramFamilies Matter in Mental Health: An Education and Support Program -- Nova Scotia
  • add this feed to my.Alltop

    schizophrenic.com

  • Drug Deaths From Schizophrenia Medication Deemed 'Inconclusive,' Says FDA

    M Tyler
    24 Mar 2015 | 10:44 am
    An FDA review of olanzapine, a drug used to treat schizophrenia, was found to be inconclusive in regards to two patient deaths, according to a statement released by the government agency. In June 2013, the FDA reported the deaths, where two individuals were given intramuscular injections - in appropriate doses - of olanzapine (Zyprexa Relprevv) and died within a few days. Accordingly, the drug's manufacturer Eli Lilly and Company were asked to conduct animal trials to test whether or not the drug entered the patients' bloodstreams in a rapid but delayed manner - which can cause overdose, coma…
  • Finger Length in Males Could Predict Schizophrenia Risk

    M Tyler
    19 Mar 2015 | 9:32 am
    Length differences between the index finger and the ring finger in males could provide clues about schizophrenia risk, according to a recent study published in Clinical Anatomy. Researchers recruited 103 male patients with schizophrenia and compared them with 100 healthy male control subjects, setting out to find how finger, or "digit" ratio asymmetry was linked to hormonal imbalances and schizophrenia. According to the research, index fingers that are shorter than ring fingers may be linked to high testosterone exposure in utero. A future diagnostic tool? The study found there were…
  • Cognitive behavioral therapy can reduce paranoia in schizophrenics

    M Tyler
    10 Mar 2015 | 11:42 am
    Paranoid delusions, a significant problem for many people suffering from schizophrenia, could be curtailed with cognitive behavioral therapy (CBT), according to a new study. Six sessions of CBT were enough to reduce worry in schizophrenic patients, researchers found, which consequently reduced the severity of "persecutory delusions" - or paranoia. Results lasted at least six months, a press release on the study reported, and patients appeared to be happier and less fearful after the CBT sessions. Limiting worry The key to success in the therapy, researchers found, was helping patients to…
  • Pediatrics and Schizophrenia: Are Doctors Doing Their Jobs?

    M Tyler
    4 Mar 2015 | 8:22 am
    Medications used to treat schizophrenia often come with health risks, which could be more dangerous for children or teens who suffer from the condition. Researchers from the University of Vermont recently conducted a study to determine if doctors in pediatrics are prescribing young people with mental illnesses the right medications - in the right dosages at the right times. "Part of our concern is that these medicines may be getting pulled out too early in the treatment planning for things like oppositional behavior, ahead of things like behavioral therapy that could be tried first," said Dr.
  • Cannabinoids could explain schizophrenia weight gain

    M Tyler
    17 Feb 2015 | 12:19 pm
    In people with schizophrenia who are treated with the antipsychotic medication olanzapine, weight gain may be associated with certain elements in the drug that change brain chemistry and affect appetite. In the first study to link cannabinoid neurotransmitters to disordered eating habits in people with schizophrenia, researchers from the University of Montreal found that olanzapine could stimulate appetite, as well as raise glucose levels, tryglycerides and anandamide - the main cannabinoid neurotransmitter. "This result is consistent with reports in the scientific literature that an increase…
 
Log in